Merck decides it's smart to leave ALEC

Another drug company is bailing on ALEC, the group that gets business leaders together with mostly Republican state lawmakers to write so-called model legislation, generally around business. The American Legislative Exchange Council has been in the spotlight this year for support of tougher voter ID laws and self-defense gun laws. A Merck ($MRK) spokeswoman tells NJ.com that Merck reviews its memberships each fall and decides which ones meet its budget and policy priorities, and ALEC didn't make the cut this year. Johnson & Johnson ($JNJ) dropped its membership in June. Pfizer found itself the subject of criticism earlier this year for its membership in ALEC, which has been accused of inappropriate lobbying. Story | More

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.